| Factor Information | |
|---|---|
| Data ID | 2951 |
| Factor | (B-type natriuretic peptide )BNP concentrations |
| Description | N/A |
| Biomarker | YES |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | Biomarkers in adult CHD patients |
| p Value | 0.05 |
| Conclusion | A significant stepwise increase was found in the BNP concentrations with increasing disease severity (as expressed by NYHA class, p=0.01) and systemic ventricular function(p=0.05). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 640 |
| CHD Type | isolated CHD |
| CHD Subtype | TOF/SV/HRV |
| Reference | |
|---|---|
| PMID | 20211335 |
| Year | 2010 |
| Title | Usefulness of Natriuretic Peptide Levels to Predict Mortality in Adults With Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | patients' data | |
| Region | London, United Kindom | |
| Method | Kruskal-Wallis one-way analysis | |
| Race | British | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | adult CHD patients(Treatment) | adult CHD patients(Control) |
| Number | 49 | 49 |
| Age | 33.9±11.3 | 33.9±11.3 |
| Gender (Male: Female) | 23:26 | 23:26 |
| Marker Level | median concentration of BNP=52.7pg/ml(interquartile range 39.1 to 115.4) | increasing with systemic ventricular function |
